Last reviewed · How we verify

NCT05389631

Trifecta and Epic ViV Detailed Insights Into Management Strategies and Outcomes

Completed Last updated 9 October 2024
What this trial tests

trial testing no intervention in Aortic Valve Disease in 76 participants. Completed in 21 December 2023.

Timeline
17 August 2022
Primary endpoint
21 December 2023
21 December 2023

Quick facts

Lead sponsorHelios Health Institute GmbH
StatusCompleted
Study typeOBSERVATIONAL
Enrollment76
Start date17 August 2022
Primary completion21 December 2023
Estimated completion21 December 2023
Sites5 locations across Belgium, Netherlands, Germany

Drugs / interventions tested

Conditions studied

Sponsor

Helios Health Institute GmbH

Who can join

Eligibility, any sex, with Aortic Valve Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Non-randomized, open label, non-interventional, multicenter registry to describe risk factors, management strategies, and clinical outcomes in patients undergoing Valve in Valve (ViV) transcatheter aortic valve implantation (TAVI) in a previously implanted Trifecta or Epic valve using retrospective registry data from large volume centers

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The International Trifecta<sup>TM</sup> and Epic<sup>TM</sup> Valve-in-Valve Registry: Insights Into Clinical & Hemodynamic Outcomes.
    Raschpichler M, Abdel-Wahab M, Curzen N, Wilbring M, et al · · 2025 · PMID 40148747 · DOI 10.1002/ccd.31492

Verify or expand the search:

Other trials of no intervention

Trials testing the same drug.

Other recruiting trials for Aortic Valve Disease

Currently open trials in the same condition.

Other Helios Health Institute GmbH trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05389631.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing